anterior lens capsules; plasma
-
apoptosis (inhibits); oxidative phosphorylation (other); ceRNA regulation (promotes)
RNA-seq; RT-qPCR; Luciferase Reporter Assay; Bioinformatics Analysis; Clinical Sample Validation
Potential biomarker/target for ARC prevention and treatment; plasma circZNF292 is dramatically down-regulated in ARC patients.
circZNF292 is down-regulated in ARC lens anterior capsule (and also in plasma) and acts as an antioxidant-related circRNA. It functions as a ceRNA by sponging miR-23b-3p, thereby de-repressing anti-oxidative genes (e.g., GPX3, SIRT1, PRDX6, ALDH6A1, SOD1) and potentially reducing oxidative stress-induced apoptosis of lens epithelial cells.
0.5135
Profiling of circular RNAs in age-related cataract reveals circZNF292 as an antioxidant by sponging miR-23b-3p.
combined biological and clinical study